Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOGEN INC. Director's Dealing 2010

Sep 7, 2010

30291_dirs_2010-09-07_415fd4ef-78ac-46e0-8107-bb36111c3ecd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2010-09-04

Reporting Person: Clancy Paul J (Executive VP and CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-09-04 Common Stock F 1114 $56.24 Disposed 45783 Direct